Journals / Retina-Vitreus / 2012 / Cilt: 20 - Sayı: 4

Nonarteritic anterior ischemic optic neuropathy in a Young pa - tient with dysfibrinogenemia and homocysteinemia

Disfibrinojenemi ve homosisteinemili genç bir olguda nonarteritik anterior iskemik optik nöropati

Pages
312–314
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Younger patients with NAION should be examined for thromboembolic diseases and preventive measures should be taken if any diseases are found.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 47-year-old female patient was admitted to our clinic with the chief complaint of sudden onset visual loss in the right eye that had occurred 25 years ago.
📊
Key Findings & Data:Her visual acuity was count fingers OD and was 1.0 OS with the Snellen chart.
💡
Conclusion & Impact:Younger patients with NAION should be examined for thromboembolic diseases and preventive measures should be taken if any diseases are found.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 47-year-old female patient was admitted to our clinic with the chief complaint of sudden onset visual loss in the right eye that had occurred 25 years ago. Her visual acuity was count fingers OD and was 1.0 OS with the Snellen chart. The anterior segment evaluation showed normal OU. There was optic atrophy in the OD and the fundus examination showed a normal OS. There was a relative afferent pupillary defect (RAPD) in the OD. The patient had had two still-births and two normal deliveries in her past medical history. A laboratory work-up was performed with a preliminary diagnosis of nonarteritic ischemic optic neuropathy and mutations were found in the methylene tetrahydrofolate reductase (MTHFR) C677T and β - fibrinogen genes. Younger patients with NAION should be examined for thromboembolic diseases and preventive measures should be taken if any diseases are found.

Özet

Sağ gözde 25 yıl önce aniden meydana gelen görme kaybı şikayetiyle kliniğimize başvuran 47 yaşındaki kadın hastanın, görme keskinliği sağ gözde el hareketi seviyesinde, sol gözde ise tamdı. Biomikroskobik muayeneleri her iki gözde doğaldı. Fundus muayenesinde sağ gözde optik atrofi mevcut olup, sol göz normaldi. Sağ gözde rölatif afferent pupil defekti (RAPD) mevcuttu. Hastanın öz geçmişi sorgulandığında 2 ölü doğum, 2 normal doğum yaptığı öğrenildi. Geçirilmiş nonarteritik anterior iskemik optik nöropati (NAİON) ön tanısıyla takibe alınan hastanın yapılan genetik analiz sonucunda, metilen tetrahidrofolat redüktaz (MTHFR) C677T ve β- fibrinojen geninde mutasyon saptandı. NAİON geçiren genç hastalar trom -boembolik hastalıklar açısından araştırılmalı ve olası embolik hadiselerden korunmalıdır.

🔖

Cite This Article

YUSUFOĞLU, E., ALTIPARMAK, U. E., FEN, T., ÜNEY, G., ACAR, M. A., ÖRNEK, F. (2012). Nonarteritic anterior ischemic optic neuropathy in a Young pa - tient with dysfibrinogenemia and homocysteinemia. Retina-Vitreus, Cilt: 20 - Sayı: 4, 312–314. https://ajindex.com/articles/308174

References (17)

  1. Felekis T, Kolaitis NI, Kitsos G, et al. Thrombophilic risk factors in the pathogenesis of non-arteritic anterior ischemic optic neuropathy patients. Graefes Arch Clin Exp Ophthalmol 2010
  2. Hayreh SS. Non-arteritic anterior ischemic optic neuropathy and thrombophilia. Graefes Arch Clin Exp Ophthalmol 2009
  3. Yağcı R, Altıparmak UE, Şatana BS, et al. Metilentetrahidrofo - lat redüktaz C677T mutasyonlu genç bir olguda iskemik optik nöropati. Ret-Vit 2006
  4. Salomon O, Huna- Baron R, Kurtz S, et al. Analysis prothrom - botic and vaskular risc factors in patients with non-arteritic ischemic optic neuropthy. Ophthalmology 1999
  5. Nagy V, Steiber Z, Takacs S, et al. Thrombophilic screening for non-arteritic anterior ischemic optic neuropthy. Graefes Arch Clin Exp Ophthalmol 2006
  6. Newman JN, Dickersin K, Kaufman D, et al. Characteristics of patients with non-arteritic ischemic optic neuropthy eligible fort the ischemic optic neuropthy decompression trial. Arch Ophthalmol 1996
  7. Hattenhauer MG, Leavitt JA, Hodge DO, et al. Incidence of nonarteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1997
  8. Mojon SD, Hedges RT III, Ehrenberg B, et al. Association between sleep apnea syndrome and non-arteritic anterior ischemic optic neuropathy. Arch Ophthalmol 2002
  9. Arnold AC, Levin LA. Treatment of ischemic optic neuropathy. Semin Ophthalmol 2002
  10. Hayreh SS, Joos MK, Podhajsky Ap, et al. Systemic diseases associated with non-arteritic anterior ischemic optic neuropathy. Am J Ophthalmol 1994
  11. Beck WR, Savino JP, Repka XM, et al. Optic disc structure in anterior ischemic optic neuropathy. Ophthalmology 1984
  12. Hayreh SS, Podhajsky AP, Zimmerman B. Non-arteritic anterior ischemic optic neuropathy: time of onset of visual loss. Am J Ophthalmol 1997
  13. Behbelhani R, Marthews MK, Sergott RC, et al. Non-arteritic anterior ischemic optic neuropathy in patients with sleep apnea while being treated with continuous positive airway pressure. Am J Ophthalmol 2005
  14. Chung SM, Gay CA, McCrary JA: 3rd. Nonarteritic ischemic optic neuropathy. The impact of tobacco use. Ophthalmol 1994
  15. Chisholm IA. Optic neuropathy of recurrent blood loss. Br J Ophthalmol 1969
  16. Hayreh SS. Anterior ischemic optic neuropathy. IV. Occurrence after cataract extraction. Arch Ophthalmol 1980
  17. De Moerloose